Granahan Investment Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Granahan Investment Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-211,185	Closed	-$836K	–	182
2022 Q3	$836K	Buy	211,185 +88,436	+72%	+$544K	0.03%	166
2022 Q2	$680K	Sell	122,749 -175,203	-59%	-$1.43M	0.02%	169
2022 Q1	$4.37M	Buy	297,952 +150,857	+103%	+$2.02M	0.11%	140
2021 Q4	$2.32M	Buy	147,095 +51,271	+54%	+$1.23M	0.05%	175
2021 Q3	$3.08M	Buy	95,824 +86,641	+943%	+$3.04M	0.06%	176
2021 Q2	$382K	Buy	+9,183	New	+$377K	0.01%	192
2021 Q1	–	Sell	-16,679	Closed	-$541K	–	210
2020 Q4	$541K	Sell	16,679 -39,527	-70%	-$560K	0.01%	188
2020 Q3	$672K	Buy	+56,206	New	+$651K	0.02%	172

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Granahan Investment Management's DMTK Position: Q4 2022 in Review

Granahan Investment Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 211,185 shares — an estimated $836K sold.

Granahan Investment Management first reported a position in DMTK in Q3 2020 and held it in 8 quarters. The position peaked at $4.37M in Q1 2022. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

Granahan Investment Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Granahan Investment Management sold 211,185 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $836K.
Granahan Investment Management first reported a position in DermTech, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
Granahan Investment Management's DermTech, Inc. Common Stock position peaked at $4.37M in Q1 2022.
94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Granahan Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.